India's Glenmark Life Sciences jumps nearly 3% on block deal
** Shares of pharmaceutical company Glenmark Life Sciences
GLEM.NS rise as much as 2.93% to 386.30 rupees
** GLEM is most active in over five months since October
** About 443,068 shares change hands in block, at a price of
378.15 rupees per share - Refinitiv data
** Trading volume is 515,775 shares as of 12:02 p.m. IST,
more than 5x the 30-day avg
(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463))
Recent news on Alivus Life Sciences
See all newsBrief: Alivus Life Sciences Incorporates Subsidiary Alivus Life Sciences Do Brasil Ltda In Brazil
Brief: Alivus Life Sciences To Buy 76% Stake In Iqgen-X Pharma For Approx 91.2 Million Rupees
India's Alivus rises to 15-month high as brokerages optimistic about drugmaker's annual outlook
India's Alivus Life Sciences rises after quarterly profit increase
Brief: Alivus Life Sciences Ltd March-Quarter Profit 1.63 Billion Rupees